Sign in

CIK 0001798749

  • Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831377888
Phone
+1 781-312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-02 Katabi Maha Director Grant or award · Stock Option (Right to Buy) +3,519 $13.49 $47K 3,519
2024-01-02 GRAYZEL DAVID S. Director Grant or award · Stock Option (Right to Buy) +3,186 $13.49 $43K 3,186
2023-12-27 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise 10b5-1 +125 $2.14 $268 3,376
2023-12-27 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −125 $24.50 $3K 3,251
2023-12-27 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −25 16,269
2023-12-27 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −100 109,540
2023-12-20 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −4,000 $19.50 $78K 3,251
2023-12-20 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −2,924 9,023
2023-12-20 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −1,076 10,027
2023-12-14 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise 10b5-1 +9,897 $1.74 $17K 13,148
2023-12-14 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −9,897 $19.50 $193K 3,251
2023-12-14 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −2,700 12,744
2023-12-14 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −7,197 10,306
2023-12-13 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise 10b5-1 +4,000 $1.74 $7K 7,251
2023-12-13 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise 10b5-1 +2,103 $1.74 $4K 5,354
2023-12-13 Gillies Hunter CHIEF MEDICAL OFFICER Sale 10b5-1 −2,103 $19.50 $41K 3,251
2023-12-13 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −653 15,444
2023-12-13 Gillies Hunter CHIEF MEDICAL OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −1,450 17,503
2023-12-06 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +2,411 $1.74 $4K 3,702
2023-12-06 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +7,872 $2.14 $17K 11,574

Page 10 of 16 · 315 trades